Patents by Inventor Amin R. MAZLOOM

Amin R. MAZLOOM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and processes for non-invasive assessment of genetic variations
    Patent number: 11462298
    Abstract: Provided herein are methods, processes and apparatuses for non-invasive assessment of genetic variations that make use of decision analyses. The decision analyses sometimes include segmentation analyses and/or odds ratio analyses.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: October 4, 2022
    Assignee: Sequenom, Inc.
    Inventors: Chen Zhao, Zeljko Dzakula, Cosmin Deciu, Sung Kyun Kim, Amin R. Mazloom, Gregory Hannum, Mathias Ehrich
  • PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
    Publication number: 20220268781
    Abstract: Disclosed herein are methods, kits, tests, and systems for detecting, predicting, monitoring, or ruling out preeclampsia in pregnant women. Also provided herein are novel diagnostic markers, methods of data analysis, assay formats, and kits employing such markers to improve one or more characteristics of a test for identifying or ruling out preeclampsia based on biomarkers from patient samples.
    Type: Application
    Filed: March 10, 2022
    Publication date: August 25, 2022
    Inventors: Matthew COOPER, Sharat SINGH, Karen A. F. COPELAND, Lyndal HESTERBERG, Amin R. MAZLOOM, Mohammad ABBASI, Richard Giulio DEL MASTRO
  • Preeclampsia biomarkers and related systems and methods
    Patent number: 11333672
    Abstract: Disclosed herein are methods, kits, tests, and systems for detecting, predicting, monitoring, or ruling out preeclampsia in pregnant women. Also provided herein are novel diagnostic markers, methods of data analysis, assay formats, and kits employing such markers to improve one or more characteristics of a test for identifying or ruling out preeclampsia based on biomarkers from patient samples.
    Type: Grant
    Filed: April 19, 2021
    Date of Patent: May 17, 2022
    Assignee: PROGENITY, INC.
    Inventors: Matthew Cooper, Sharat Singh, Karen A. F. Copeland, Lyndal Hesterberg, Amin R. Mazloom, Mohammad Abbasi, Richard Giulio Del Mastro
  • PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
    Publication number: 20210293824
    Abstract: Disclosed herein are methods, kits, tests, and systems for detecting, predicting, monitoring, or ruling out preeclampsia in pregnant women. Also provided herein are novel diagnostic markers, methods of data analysis, assay formats, and kits employing such markers to improve one or more characteristics of a test for identifying or ruling out preeclampsia based on biomarkers from patient samples.
    Type: Application
    Filed: April 19, 2021
    Publication date: September 23, 2021
    Inventors: Matthew COOPER, Sharat SINGH, Karen A. F. COPELAND, Lyndal HESTERBERG, Amin R. MAZLOOM, Mohammad ABBASI, Richard Giulio DEL MASTRO
  • METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS
    Publication number: 20200265921
    Abstract: Provided herein are methods, processes and apparatuses for non-invasive assessment of genetic variations that make use of decision analyses. The decision analyses sometimes include segmentation analyses and/or odds ratio analyses.
    Type: Application
    Filed: April 29, 2020
    Publication date: August 20, 2020
    Inventors: Chen ZHAO, Zeljko DZAKULA, Cosmin DECIU, Sung Kyun KIM, Amin R. MAZLOOM, Gregory HANNUM, Mathias EHRICH
  • PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
    Publication number: 20200264188
    Abstract: Disclosed herein are methods, kits, tests, and systems for detecting, predicting, monitoring, or ruling out preeclampsia in pregnant women. Also provided herein are novel diagnostic markers, methods of data analysis, assay formats, and kits employing such markers to improve one or more characteristics of a test for identifying or ruling out preeclampsia based on biomarkers from patient samples.
    Type: Application
    Filed: September 13, 2018
    Publication date: August 20, 2020
    Inventors: Matthew COOPER, Sharat SINGH, Karen A.F. COPELAND, Lyndal HESTERBERG, Amin R. MAZLOOM, Mohammad ABBASI, Richard Giulio DEL MASTRO
  • Methods and processes for non-invasive assessment of genetic variations
    Patent number: 10699800
    Abstract: Provided herein are methods, processes and apparatuses for non-invasive assessment of genetic variations that make use of decision analyses. The decision analyses sometimes include segmentation analyses and/or odds ratio analyses.
    Type: Grant
    Filed: May 23, 2014
    Date of Patent: June 30, 2020
    Assignee: Sequenom, Inc.
    Inventors: Chen Zhao, Zeljko Dzakula, Cosmin Deciu, Sung Kyun Kim, Amin R. Mazloom, Gregory Hannum, Mathias Ehrich
  • METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS
    Publication number: 20200160934
    Abstract: Provided herein are methods, processes and apparatuses for non-invasive assessment of genetic variations.
    Type: Application
    Filed: November 27, 2019
    Publication date: May 21, 2020
    Applicant: Sequenom, Inc.
    Inventors: Zeljko Dzakula, Amin R. Mazloom, Cosmin Deciu, Huiquan Wang
  • Methods and processes for non-invasive assessment of genetic variations
    Patent number: 10497461
    Abstract: Provided herein are methods, processes and apparatuses for non-invasive assessment of genetic variations.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: December 3, 2019
    Assignee: Sequenom, Inc.
    Inventors: Zeljko Dzakula, Amin R. Mazloom, Cosmin Deciu, Huiquan Wang
  • PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
    Publication number: 20190079097
    Abstract: Disclosed herein are methods, kits, tests, and systems for detecting, predicting, monitoring, or ruling out preeclampsia in pregnant women. Also provided herein are novel diagnostic markers, methods of data analysis, assay formats, and kits employing such markers to improve one or more characteristics of a test for identifying or ruling out preeclampsia based on biomarkers from patient samples.
    Type: Application
    Filed: September 25, 2018
    Publication date: March 14, 2019
    Inventors: Matthew COOPER, Sharat SINGH, Karen A.F. COPELAND, Lyndal HESTERBERG, Amin R. MAZLOOM, Mohammad ABBASI, Richard GIULIO DEL MASTRO
  • METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS
    Publication number: 20160224724
    Abstract: Provided herein are methods, processes and apparatuses for non-invasive assessment of genetic variations that make use of decision analyses. The decision analyses sometimes include segmentation analyses and/or odds ratio analyses.
    Type: Application
    Filed: May 23, 2014
    Publication date: August 4, 2016
    Inventors: Chen ZHAO, Zeljko DZAKULA, Cosmin DECIU, Sung Kyun KIM, Amin R. MAZLOOM, Gregory HANNUM, Mathias EHRICH
  • METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS
    Publication number: 20130261983
    Abstract: Provided herein are methods, processes and apparatuses for non-invasive assessment of genetic variations.
    Type: Application
    Filed: March 12, 2013
    Publication date: October 3, 2013
    Inventors: Zeljko DZAKULA, Amin R. MAZLOOM, Cosmin DECIU, Huiquan WANG